
WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Tom Frinzi, executive chairman of ViaLase, discusses a product in clinical trials for the noninvasive treatment of open-angle glaucoma in a stand-alone procedure.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Tom Frinzi, executive chairman of ViaLase, discusses a product in clinical trials for the noninvasive treatment of open-angle glaucoma in a stand-alone procedure.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Tom Frinzi, executive chairman of ViaLase, discusses a product in clinical trials for the noninvasive treatment of open-angle glaucoma in a stand-alone procedure.